marijuana stocks news

NTRR Plans Bold Expansion Into New Nutraceutical Markets With Versatile Inhalation Technology

TAMPA, Fla.–(BUSINESS WIRE)–

As Neutra Corp. (NTRR) continues to develop new nutraceutical applications for the Diamond Anvil vapor pen, the company is making plans to expose the innovative product offering to potentially lucrative new global markets beyond the legal cannabis industry.

As the popularity of smoke-free delivery devices continues to rise in the legal cannabis industry, Neutra Corp. (NTRR) announced plans today to adapt the technology to deliver vitamins, minerals and other nutraceuticals across multiple industries.

“The success of vaporizers and other smoke-free devices in the cannabis industry has opened our eyes to this technology’s potential,” said NTRR CEO Chris Brown. “We are in the midst of developing new methods to deliver vitamins, herbal extractions, anti-smoking aids and other nutraceutical remedies that are currently taken in more unpleasant and inefficient ways.”

NTRR already has extensive experience with electronic inhalation devices. The Diamond Anvil vapor pen, originally developed by Diamond Anvil Designs, is one of the most versatile portable vaporizers ever devised. Unlike many competing products, the Diamond Anvil can accommodate dry herbs, oils, waxes and other extractions. The device features customizable power levels, multi-substance vaporization capacity and best-in-class durability, making it a unique and groundbreaking product in the fast-growing vaporization industry.

NTRR acquired Diamond Anvil Designs last year in order to market and develop a lightweight, portable, smoke-free delivery system that will stand out from competing products in a rapidly growing marketplace. Currently, the company is testing a redesigned pen featuring a new wickless atomizer and more durable tubing to improve the Diamond Anvil’s functionality even further.

By marketing vaporizers and other inhalation technologies to health-conscious consumers in new industries, NTRR hopes to significantly expand its earnings potential.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPRF), INSYS Therapeutics, Inc. (INSY) and ENDEXX Corp. (EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contact:
Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published.

You May Also Like

Zoned Properties, Inc. (ZDPY) CEO Bryan McLaren to Present at Upcoming Investor Conferences

Zoned Properties’ CEO Bryan McLaren to Present at Upcoming Investor Conferences Zoned…

22nd Century Group, Inc. (XXII) and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation

22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation 22nd Century…

4Front Ventures Corp. (FFNTF) Announces Closings of $5.8 Million U.S. Private Placement

4Front Ventures Announces Closings of $5.8 Million U.S. Private Placement and Sale…

 Organigram Holdings, Inc. (OGRMF) Shares Climb as Canada Cannabis Legalization Draws Near

Organigram Holdings Shares Climb as Canada Cannabis Legalization Draws Near Traders News…